Loading…
Lobbying Spend
—
Filings
21
Firms Hired
2
Active Period
2005–2009
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Food and Drug Administration Amendments Act of 2007
2008 · fourth_quarter · Firm: SQUIRE PATTON BOGGS
Prescription drug abuse, misuse, and diversion Development of abuse-deterrent drug formulations Implementation of P.L. 110-85/HR 3580, Food and Drug Administration Amendments Act of 2007 (section on post-market drug safety)
Client expense: — · Firm income: $60,000
Matched citations: HR 3580
Food and Drug Administration Amendments Act of 2007
2008 · third_quarter · Firm: SQUIRE PATTON BOGGS
Prescription drug abuse, misuse, and diversion Development of abuse-deterrent drug formulations Implementation of P.L. 110-85/HR 3580, Food and Drug Administration Amendments Act of 2007 (section on post-market drug safety)
Client expense: — · Firm income: $60,000
Matched citations: HR 3580
Food and Drug Administration Amendments Act of 2007
2008 · second_quarter · Firm: SQUIRE PATTON BOGGS
Prescription drug abuse, misuse, and diversion Development of abuse-deterrent drug formulations Implementation of P.L. 110-85/HR 3580, Food and Drug Administration Amendments Act of 2007 (section on post-market drug safety)
Client expense: — · Firm income: $40,000
Matched citations: HR 3580
Food and Drug Administration Amendments Act of 2007
2008 · first_quarter · Firm: SQUIRE PATTON BOGGS
Prescription drug abuse, misuse, and diversion Development of abuse-deterrent drug formulations Implementation of P.L. 110-85/HR 3580, Food and Drug Administration Amendments Act of 2007 (section on post-market drug safety)
Client expense: — · Firm income: $40,000
Matched citations: HR 3580
Food and Drug Administration Amendments Act of 2007
2007 · year_end · Firm: SQUIRE PATTON BOGGS
Prescription drug abuse, misuse, and diversion Development of abuse-deterrent drug formulations P.L. 110-85/HR 3580, Food and Drug Administration Act of 2007 (section on post-market drug safety)
Client expense: — · Firm income: $80,000
Matched citations: HR 3580
Food and Drug Administration Amendments Act of 2007
2007 · year_end · Firm: SQUIRE PATTON BOGGS
Prescription drug abuse, misuse, and diversion Development of abuse-deterrent drug formulations P.L. 110-85/HR 3580, Food and Drug Administration Act of 2007 (section on post-market drug safety)
Client expense: — · Firm income: $80,000
Matched citations: HR 3580
Food and Drug Administration Amendments Act of 2007
2007 · year_end · Firm: SQUIRE PATTON BOGGS
Prescription drug abuse, misuse, and diversion Development of abuse-deterrent drug formulations P.L. 110-85/HR 3580, Food and Drug Administration Act of 2007 (section on post-market drug safety)
Client expense: — · Firm income: $80,000
Matched citations: HR 3580
Source: Senate LDA